应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NKTR 内克塔治疗
交易中 12-08 14:22:50 EST
57.60
+0.70
+1.23%
最高
58.94
最低
56.54
成交量
22.69万
今开
58.00
昨收
56.90
日振幅
4.21%
总市值
11.72亿
流通市值
10.13亿
总股本
2,034万
成交额
1,311万
换手率
1.29%
流通股本
1,759万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nektar Therapeutics第三季度每股收益为-1.87美元
投资观察 · 11-20
Nektar Therapeutics第三季度每股收益为-1.87美元
内克塔治疗2025财年第三财季实现净利润-35.52百万美元,同比增加4.16%
市场透视 · 11-16
内克塔治疗2025财年第三财季实现净利润-35.52百万美元,同比增加4.16%
内克塔治疗盘中异动 急速拉升5.21%
市场透视 · 11-15
内克塔治疗盘中异动 急速拉升5.21%
内克塔治疗宣布Rezpegaldesleukin的Rezolve-Ad 2B期试验结果入选2025年欧洲皮肤病与性病学会年会重磅口头报告
美股速递 · 09-09
内克塔治疗宣布Rezpegaldesleukin的Rezolve-Ad 2B期试验结果入选2025年欧洲皮肤病与性病学会年会重磅口头报告
内克塔治疗盘中异动 股价大跌5.12%
市场透视 · 08-20
内克塔治疗盘中异动 股价大跌5.12%
内克塔治疗盘中异动 早盘大幅拉升7.40%报23.36美元
市场透视 · 08-08
内克塔治疗盘中异动 早盘大幅拉升7.40%报23.36美元
内克塔治疗盘中异动 早盘股价大涨5.13%报22.79美元
市场透视 · 08-01
内克塔治疗盘中异动 早盘股价大涨5.13%报22.79美元
内克塔治疗盘中异动 股价大跌5.16%报23.71美元
市场透视 · 07-28
内克塔治疗盘中异动 股价大跌5.16%报23.71美元
内克塔治疗7月22日成交额为1434.03万美元
市场透视 · 07-23
内克塔治疗7月22日成交额为1434.03万美元
内克塔治疗7月21日成交额为1485.21万美元
市场透视 · 07-22
内克塔治疗7月21日成交额为1485.21万美元
内克塔治疗7月17日成交额为3353.97万美元
市场透视 · 07-18
内克塔治疗7月17日成交额为3353.97万美元
内克塔治疗7月16日成交额为2297.95万美元
市场透视 · 07-17
内克塔治疗7月16日成交额为2297.95万美元
内克塔治疗盘中异动 早盘股价大跌5.13%报23.16美元
市场透视 · 07-15
内克塔治疗盘中异动 早盘股价大跌5.13%报23.16美元
内克塔治疗盘中异动 早盘股价大跌5.04%
市场透视 · 07-14
内克塔治疗盘中异动 早盘股价大跌5.04%
内克塔治疗7月10日成交额为3959.46万美元
市场透视 · 07-11
内克塔治疗7月10日成交额为3959.46万美元
内克塔治疗盘中异动 股价大涨5.46%
市场透视 · 07-10
内克塔治疗盘中异动 股价大涨5.46%
内克塔治疗盘中异动 股价大跌5.20%报22.25美元
市场透视 · 07-08
内克塔治疗盘中异动 股价大跌5.20%报22.25美元
内克塔治疗盘中异动 早盘急速下跌5.05%
市场透视 · 07-07
内克塔治疗盘中异动 早盘急速下跌5.05%
内克塔治疗7月2日成交额为5274.27万美元
市场透视 · 07-03
内克塔治疗7月2日成交额为5274.27万美元
内克塔治疗7月1日成交额为9598.57万美元
市场透视 · 07-02
内克塔治疗7月1日成交额为9598.57万美元
加载更多
公司概况
公司名称:
内克塔治疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nektar Therapeutics于1990年在加州成立,并于1998年重新在特拉华州注册。该公司是一家临床阶段、研究型药物发现生物制药公司,专注于发现和开发免疫治疗领域的创新药物。在这个不断增长的领域内,该公司致力于创造新的免疫调节剂,选择性地诱导、放大、减弱或阻止免疫反应,以达到预期的治疗效果。
发行价格:
--
{"stockData":{"symbol":"NKTR","market":"US","secType":"STK","nameCN":"内克塔治疗","latestPrice":57.6,"timestamp":1765221770391,"preClose":56.9,"halted":0,"volume":226875,"delay":0,"floatShares":17594200,"shares":20341589,"eps":-7.899717,"marketStatus":"交易中","change":0.7,"latestTime":"12-08 14:22:50 EST","open":58,"high":58.9358,"low":56.54,"amount":13107817.696875,"amplitude":0.042105,"askPrice":57.87,"askSize":101,"bidPrice":57.63,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-7.899717,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765227600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":56.9,"preHourTrading":{"tag":"盘前","latestPrice":57.77,"preClose":56.9,"latestTime":"09:29 EST","volume":1896,"amount":108432.01248,"timestamp":1765204180119},"postHourTrading":{"tag":"盘后","latestPrice":56.9,"preClose":56.9,"latestTime":"19:35 EST","volume":3846,"amount":218858.3588,"timestamp":1764981339607},"volumeRatio":0.529458,"impliedVol":1.4709,"impliedVolPercentile":0.6867},"requestUrl":"/m/hq/s/NKTR","defaultTab":"news","newsList":[{"id":"1173506245","title":"Nektar Therapeutics第三季度每股收益为-1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173506245","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173506245?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:04","pubTimestamp":1763571844,"startTime":"0","endTime":"0","summary":"11月6日 - 内克塔治疗第三季度的运营收入为-316,720,000美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2583275656","title":"内克塔治疗2025财年第三财季实现净利润-35.52百万美元,同比增加4.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583275656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583275656?lang=zh_cn&edition=full","pubTime":"2025-11-16 00:02","pubTimestamp":1763222561,"startTime":"0","endTime":"0","summary":"11月16日,内克塔治疗公布财报,公告显示公司2025财年第三财季净利润为-35.52百万美元,同比增加4.16%;其中营业收入为11.79百万美元,同比减少51.12%,每股基本收益为-1.87美元。从资产负债表来看,内克塔治疗总负债2.16亿美元,其中短期债务22.18百万美元,资产负债比为1.40,流动比率为0.05。机构评级:截至2025年11月16日,当前有7家机构对内克塔治疗目标价做出预测,其中目标均价为93.86美元,其中最低目标价为30.00美元,最高目标价为120.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111600033095068119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111600033095068119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR"],"gpt_icon":0},{"id":"2583226656","title":"内克塔治疗盘中异动 急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583226656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583226656?lang=zh_cn&edition=full","pubTime":"2025-11-15 03:10","pubTimestamp":1763147426,"startTime":"0","endTime":"0","summary":"北京时间2025年11月15日03时10分,内克塔治疗股票出现波动,股价大幅上涨5.21%。截至发稿,该股报56.76美元/股,成交量35.4551万股,换手率1.74%,振幅7.41%。机构评级方面,在所有9家参与评级的机构中,78%的券商给予买入建议,11%的券商给予持有建议,11%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.90%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115031027a4a239c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115031027a4a239c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"1194489688","title":"内克塔治疗宣布Rezpegaldesleukin的Rezolve-Ad 2B期试验结果入选2025年欧洲皮肤病与性病学会年会重磅口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1194489688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194489688?lang=zh_cn&edition=full","pubTime":"2025-09-09 19:01","pubTimestamp":1757415708,"startTime":"0","endTime":"0","summary":"内克塔治疗宣布Rezpegaldesleukin的Rezolve-Ad 2B期试验结果入选2025年欧洲皮肤病与性病学会年会重磅口头报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2561483893","title":"内克塔治疗盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561483893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561483893?lang=zh_cn&edition=full","pubTime":"2025-08-20 22:17","pubTimestamp":1755699448,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日22时17分,内克塔治疗股票出现波动,股价急速下挫5.12%。截至发稿,该股报25.35美元/股,成交量9.5023万股,换手率0.50%,振幅5.46%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.57%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820221728a6f16568&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820221728a6f16568&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2557957859","title":"内克塔治疗盘中异动 早盘大幅拉升7.40%报23.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557957859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557957859?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:32","pubTimestamp":1754659946,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时32分,内克塔治疗股票出现波动,股价急速拉升7.40%。截至发稿,该股报23.36美元/股,成交量2.0432万股,换手率0.12%,振幅2.07%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体跌幅为0.08%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213226a6db2070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213226a6db2070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2556817899","title":"内克塔治疗盘中异动 早盘股价大涨5.13%报22.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817899?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:12","pubTimestamp":1754061141,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时12分,内克塔治疗股票出现异动,股价急速拉升5.13%。截至发稿,该股报22.79美元/股,成交量19.0473万股,换手率1.10%,振幅7.82%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.03%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080123122194c933ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080123122194c933ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2555708781","title":"内克塔治疗盘中异动 股价大跌5.16%报23.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555708781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555708781?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:44","pubTimestamp":1753717458,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时44分,内克塔治疗股票出现波动,股价大幅下挫5.16%。截至发稿,该股报23.71美元/股,成交量23.6647万股,换手率1.37%,振幅6.80%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为0.02%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823441994bf9fbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823441994bf9fbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2553818296","title":"内克塔治疗7月22日成交额为1434.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553818296","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553818296?lang=zh_cn&edition=full","pubTime":"2025-07-23 12:22","pubTimestamp":1753244572,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,内克塔治疗成交额为1434.03万美元,成交额较昨日减少3.45%,当日成交量为58.01万股。内克塔治疗于2025年7月22日跌1.25%,报24.48美元,该股过去5个交易日涨2.86%,年初至今涨75.48%,过去60日涨121.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723122254a45decb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723122254a45decb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2553251289","title":"内克塔治疗7月21日成交额为1485.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553251289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553251289?lang=zh_cn&edition=full","pubTime":"2025-07-22 12:19","pubTimestamp":1753157963,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日,内克塔治疗成交额为1485.21万美元,成交额较昨日减少48.00%,当日成交量为59.80万股。内克塔治疗于2025年7月21日跌0.6%,报24.79美元,该股过去5个交易日涨1.56%,年初至今涨77.71%,过去60日涨140.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722121927a45b3b62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722121927a45b3b62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2552945903","title":"内克塔治疗7月17日成交额为3353.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552945903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552945903?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:16","pubTimestamp":1752812171,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日,内克塔治疗成交额为3353.97万美元,成交额较昨日增加45.96%,当日成交量为131.13万股。内克塔治疗于2025年7月17日涨10.48%,报26.67美元,该股过去5个交易日涨6.25%,年初至今涨91.18%,过去60日涨184.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121612a6b1307b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718121612a6b1307b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2552170681","title":"内克塔治疗7月16日成交额为2297.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552170681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552170681?lang=zh_cn&edition=full","pubTime":"2025-07-17 12:15","pubTimestamp":1752725742,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日,内克塔治疗成交额为2297.95万美元,成交额较昨日减少16.15%,当日成交量为95.85万股。内克塔治疗于2025年7月16日涨1.43%,报24.14美元,该股过去5个交易日涨3.34%,年初至今涨73.05%,过去60日涨153.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717121544a6aed4b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717121544a6aed4b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2551619579","title":"内克塔治疗盘中异动 早盘股价大跌5.13%报23.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551619579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551619579?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:25","pubTimestamp":1752593125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日23时25分,内克塔治疗股票出现异动,股价快速跳水5.13%。截至发稿,该股报23.16美元/股,成交量33.2685万股,换手率1.92%,振幅6.45%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体跌幅为0.25%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152325259543a405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152325259543a405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2551187618","title":"内克塔治疗盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187618?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:19","pubTimestamp":1752506361,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时19分,内克塔治疗股票出现波动,股价急速下挫5.04%。截至发稿,该股报23.75美元/股,成交量21.5865万股,换手率1.25%,振幅5.56%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为1.12%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423192297a5d5fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423192297a5d5fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2550100607","title":"内克塔治疗7月10日成交额为3959.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550100607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550100607?lang=zh_cn&edition=full","pubTime":"2025-07-11 12:23","pubTimestamp":1752207829,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,内克塔治疗成交额为3959.46万美元,成交额较昨日增加33.42%,当日成交量为162.34万股。内克塔治疗于2025年7月10日涨7.45%,报25.1美元,该股过去5个交易日跌1.68%,年初至今涨79.93%,过去60日涨170.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711122350a443e9cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711122350a443e9cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2550650854","title":"内克塔治疗盘中异动 股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650854?lang=zh_cn&edition=full","pubTime":"2025-07-10 02:12","pubTimestamp":1752084764,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日02时12分,内克塔治疗股票出现波动,股价快速上涨5.46%。截至发稿,该股报23.97美元/股,成交量70.8537万股,换手率4.10%,振幅5.98%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为1.29%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710021245953c6ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710021245953c6ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2549525045","title":"内克塔治疗盘中异动 股价大跌5.20%报22.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549525045?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:45","pubTimestamp":1751985936,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时45分,内克塔治疗股票出现波动,股价大幅下跌5.20%。截至发稿,该股报22.25美元/股,成交量30.5693万股,换手率1.77%,振幅6.94%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体涨幅为1.00%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708224536979e73bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708224536979e73bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2549558645","title":"内克塔治疗盘中异动 早盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558645?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:35","pubTimestamp":1751895302,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时35分,内克塔治疗股票出现波动,股价快速下挫5.05%。截至发稿,该股报23.51美元/股,成交量7.4079万股,换手率0.43%,振幅3.31%。机构评级方面,在所有8家参与评级的机构中,75%的券商给予买入建议,13%的券商给予持有建议,12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中,整体跌幅为0.59%。内克塔治疗公司简介:Nektar Therapeutics 是一家临床阶段,以研究为基础的药物发现生物制药公司,专注于发现和开发免疫治疗领域的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213503979d185d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213503979d185d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2548821304","title":"内克塔治疗7月2日成交额为5274.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548821304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548821304?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:19","pubTimestamp":1751516384,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,内克塔治疗成交额为5274.27万美元,成交额较昨日减少45.05%,当日成交量为207.64万股。内克塔治疗于2025年7月2日涨3.82%,报25.53美元,该股过去5个交易日跌12.33%,年初至今涨83.01%,过去60日涨208.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703121947a4cc7ba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703121947a4cc7ba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2548596228","title":"内克塔治疗7月1日成交额为9598.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548596228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548596228?lang=zh_cn&edition=full","pubTime":"2025-07-02 12:13","pubTimestamp":1751429605,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,内克塔治疗成交额为9598.57万美元,成交额较昨日增加47.65%,当日成交量为386.81万股。内克塔治疗于2025年7月1日跌4.84%,报24.59美元,该股过去5个交易日涨0.57%,年初至今涨76.27%,过去60日涨172.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702121335a729b7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702121335a729b7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.nektar.com","stockEarnings":[{"period":"1week","weight":-0.1274},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.4161},{"period":"6month","weight":4.6957},{"period":"1year","weight":2.719},{"period":"ytd","weight":3.0789}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nektar Therapeutics于1990年在加州成立,并于1998年重新在特拉华州注册。该公司是一家临床阶段、研究型药物发现生物制药公司,专注于发现和开发免疫治疗领域的创新药物。在这个不断增长的领域内,该公司致力于创造新的免疫调节剂,选择性地诱导、放大、减弱或阻止免疫反应,以达到预期的治疗效果。","yearOnYearQuotes":[{"month":1,"riseRate":0.548387,"avgChangeRate":0.042868},{"month":2,"riseRate":0.516129,"avgChangeRate":0.003089},{"month":3,"riseRate":0.387097,"avgChangeRate":-0.002052},{"month":4,"riseRate":0.451613,"avgChangeRate":0.01158},{"month":5,"riseRate":0.354839,"avgChangeRate":0.003107},{"month":6,"riseRate":0.40625,"avgChangeRate":0.024924},{"month":7,"riseRate":0.4375,"avgChangeRate":-0.019557},{"month":8,"riseRate":0.46875,"avgChangeRate":0.044887},{"month":9,"riseRate":0.5,"avgChangeRate":0.042479},{"month":10,"riseRate":0.375,"avgChangeRate":-0.023288},{"month":11,"riseRate":0.6875,"avgChangeRate":0.087128},{"month":12,"riseRate":0.59375,"avgChangeRate":0.022548}],"exchange":"NASDAQ","name":"内克塔治疗","nameEN":"Nektar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"内克塔治疗,NKTR,内克塔治疗股票,内克塔治疗股票老虎,内克塔治疗股票老虎国际,内克塔治疗行情,内克塔治疗股票行情,内克塔治疗股价,内克塔治疗股市,内克塔治疗股票价格,内克塔治疗股票交易,内克塔治疗股票购买,内克塔治疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}